On June 7th, 2022, 黑料社 hosted its virtual R&D Day to share the latest clinical results of our key assets, as well as our R&D strategy to position 黑料社 as a leader of microbiome therapies. This 2-hour event also included presentations from world-renowned experts in oncology and in the microbiome fields including:
- Dr. Jo毛l Dor茅 – Research Director, INRAE and Scientific Advisor at 黑料社, France
- Pr. Ernst Holler, M.D – Senior Professor on Clinical and Experimental Allo-HSCT, Dept of Internal Medicine 3, University Hospital Center Regensburg, Germany
- Pr. Florent Malard, M.D – Professor of Hematology, Saint Antoine Hospital (APHP) and Associate Professor, Sorbonne University
- Pr. Mohamad Mohty, M.D – Professor, Sorbonne University and Head of the Clinical Hematology and Cellular Department, Saint-Antoine Hospital (AP-HP), France
- Pr. Hassane Zarour, M.D – Professor of Medicine, Immunology and Dermatology, University of Pittsburgh, USA